Spinal cord compression in young children with type VI mucopolysaccharidosis

Molecular Genetics and Metabolism

Volumn 104, Issue 3, 2011, Pages 295-300

  Horovitz, Dafne Dain Gandelman ^a   Magalhães, Tatiana de Sá Pacheco Carneiro ^a   Costa, Alessandra Pena ^a   Carelli, Luis Eduardo ^b   Silva, Daniel Souza ^a   de Linhares e Riello, Anna Patricia Freitas ^c   Llerena, Juan Clinton ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INTO   (Brazil)

^c Rede Labs D'Or   (Brazil)

Author keywords

Enzyme replacement therapy; Maroteaux Lamy syndrome; Mucopolysaccharidosis type VI; Myelopathy; Spinal cord compression

Indexed keywords

GALSULFASE; RECOMBINANT ENZYME;

ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME REPLACEMENT; EVALUATION; FEMALE; FOLLOW UP; HUMAN; IMAGING; JOINT MOBILITY; MALE; MORQUIO SYNDROME; NECK; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK; SAMPLE SIZE; SCHOOL CHILD; SPINAL CORD COMPRESSION; SPINE INSTABILITY;

CHILD; CHILD, PRESCHOOL; ENZYME REPLACEMENT THERAPY; EVOKED POTENTIALS; FEMALE; HUMANS; LAMINECTOMY; MAGNETIC RESONANCE IMAGING; MALE; MUCOPOLYSACCHARIDOSIS VI; SPINAL CORD COMPRESSION; TREATMENT OUTCOME;

EID: 82455212978     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.07.019     Document Type: Article

References (33)

1. Neufeld E.F., Muenzer J. The mucopolysaccharidosis. The Metabolic and Molecular Basis of Inherited Disease 2001, III:3421. Medical Publishing Division, Mc Graw-Hill. eighth ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, K.W. Kinzler, B. Vogelstein (Eds.).
2. Clarke Lorne A. The mucopolysaccharidoses: a success of molecular medicine. Expert Rev. Mol. Med. 2008, 10:e1. 10.1017/S1462399408000550.
3. Maroteaux P., Lereque B., Marie J., Lamy M. A new dysostosis with urinary excretion of chondroitin-sulphate B. Presse Med. 1963, 71:1849-1852. [in French].
4. Wraith J.E., Clarke L.A., Beck M., Kolodny E.H., Pastores G.M., Muenzer J., Rapoport D.M., Berger K.I., Swiedler S.J., Kakkis E.D., Braakman T., Chadbourne E., Walton-Bowen K., Cox G.F. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double blinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (laronidase). J. Pediatr. 2004, 144(5):581-588.
5. Wraith J.E. The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert. Opin. Pharmacother. 2005, 6(3):489-506.
6. Sifuentes M., Doroshow R., Hoft R., Mason G., Walot I., Diament M., Okazaki S., Huff K., Cox G.F., Swiedler S.J., Kakkis E.D. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6years. Mol. Genet. Metab. 2007, 90(2):171-180.
7. Harmatz P., Whitley C.B., Waber L., Pais R., Steiner R., Plecko B., et al. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J. Pediatr. 2004, 144:574-580.
8. Harmatz P., Kramer W.G., Hopwood J.J., Simon J., Butensky E., Swiedler S.J. Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II study. Acta Paediatr. Suppl. 2005, 94:61-68.
9. Harmatz P., Ketteridge D., Giugliani R., Schwartz I., Guffon N., Teles E.L., Miranda M.C., et al. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics 2005, 115:e681-e689.
10. Harmatz P., Giugliani R., Schwartz I., Guffon N., Teles E.L., Miranda M.C., et al. Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J. Pediatr. 2006, 148:533-539.
11. Harmatz P., Giugliani R., Schwartz I.V., Guffon N., Teles E.L., Miranda M.C., et al. Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Mol. Genet. Metab. 2008, 94:469-475.
12. Harmatz P., Yu Z.F., Giugliani R., Schwartz I.V., Guffon N., Teles E.L., et al. Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J. Inherit. Metab. Dis. 2010, 33(1):51-60.
13. Munoz-Rojas M.V., Horovitz D.D.G., Jardim L.B., Raymundo M., Llerena J.C., de Magalhaes T.D., et al. Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. Mol. Genet. Metab. 2009, 99(4):346-350.
14. Kaufman H.H., Rosenberg H.S., Scott C.I., Lee Y.Y., Pruessner J.L., Butler I.J. Cervical myelopathy due to dural compression in mucopolysaccharidosis. Surg. Neurol. 1982, 17(6):404-410.
15. Kachur E., Del Maestro R. Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 2000, 47(1):223-228.
16. Vougioukas V.I., Berlis A., Kopp M.V., Korinthenberg R., Spreer J., van Velthoven V. Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr. Neurosurg. 2001, 35(1):35-38.
17. Kennedy P., Swash M., Dean M.F. Cervical cord compression in mucopolysaccharidosis. Dev. Med. Child. Neurol. 1973, 15(2):194-199.
18. Giugliani R., Harmatz P., Wraith J.E. Management guidelines for mucopolysaccharidosis VI. Pediatrics 2007, 120(2):405-418.
19. Mut M., Cila A., Varli K., Akalan N. Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin. Neurol. Neurosurg. 2005, 107:230-235.
20. Thorne J.A., Javadpour M., Hughes D.G., Wraith E., Cowie R.A. Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 2001, 48:849-853.
21. Peterson D.I., Bacchus H., Seaich L., Kelly T.E. Myelopathy associated with Maroteaux-Lamy syndrome. Arch. Neurol. 1975, 32:127-129.
22. Wald S.L., Schmidek H.H. Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 1984, 14:83-88.
23. Tamaki N., Kojima N., Tanimoto M., Suyama T., Matsumoto S. Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case. Neurosurgery 1987, 21:416-419.
24. Mills K.R. Magnetic Stimulation of the Human Nervous System 1999, Oxford University Press, ISBN 0 19 262986 7.
25. Magnetic Stimulation In Clinical Neurophysiology 2005, Elsevier, Butterworth Heinemann, ISBN 0 7506 7373 7. 2nd Ed. M. Hallet, S. Chokroverty (Eds.).
26. Di Lazzaro V., Restuccia D., Colosimo C., Tonalli P. The contribution of magnetic stimulation of the motor cortex to the diagnosis of cervical spondylotic myelopathy. Correlations of central motor conduction to distal and proximal upper limb muscles with clinical and MRI findings. Electroencephalogr. Clin. Neurophysiol. 1992, 85:311-320.
27. Maertens de Noordhout A., Remacle J.M., Pepin J.L., Born J.D., Deleaide P.J. Magnetic stimulation of the motor cortex in cervical spondylosis. Neurology 1991, 41:75-80.
28. Abbruzzese G., Dall' Agata D., et al. Electrical stimulation of the motor tracts in cervical spondylosis. J. Neurol. Neurosurg. Psychiatry 1988, 51:796-802.
29. Boor R., Miebach E., Bruhl K., Beck M. Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses. Neuropediatrics 2000, 31:122-127.
30. Blaw M.E., Langer L.O. Spinal cord compression in Morquio-Brailsford's disease. J. Pediatr. 1969, 74:593-600.
31. Dickerman R.D., Colle K.O., Bruno C.A., Schneider S.J. Craniovertebral instability with spinal cord compression in a 17-month-old boy with Sly syndrome (mucopolysaccharidosis type VII): a surgical dilemma. Spine (Phila Pa 1976) Mar 1 2004, 29(5):E92-E94.
32. Guille J.T., Sherk H.H. Congenital osseous anomalies of the upper and lower cervical spine in children. J. Bone. Join Surg. Am. 2002, 84-A:277-288.
33. Harmatz P., Hendriksz Christian, Giugliani Roberto, Nicely Helen, Waite Abigail Galsulfase [abstract]. Presented at the annual meeting of the American Society for Human Genetics 2010, MPS VI Clinical Surveillance Program Investigators, Ref Type: Abstract.